Aarey Drugs: No Deviation in Fund Utilization for Q2 FY27

Aarey Drugs & Pharmaceuticals Ltd has filed its statement on deviation or variation in the utilization of funds raised through a Preferential Issue of Convertible Warrants. The company raised ₹2,481.82 Lakhs (₹24.82 Crore) out of a total issue size of ₹3,190.00 Lakhs (₹31.90 Crore) by September 30, 2026. The funds were received through an initial allotment on May 23, 2025, and subsequent conversion of warrants during the quarter. The company reported no deviation in the use of funds, with the unutilized proceeds of ₹900.00 Lakhs (₹9.00 Crore) lying in the company's bank account pending utilization for stated objects, which include general corporate purposes and enhancing the business. The Audit Committee and auditors have provided no adverse comments.